CSTL ▼ -0.3% - Castle Biosciences, Inc. $CSTL CSTL - New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™ 24-SEP-2026 04:30 PM ET